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Abstract 
 
Abstract 
 
The ability to recognize and remove pathogens that invade the lower airway, while 
maintaining homeostasis in the lung microenvironment, is an essential function of the 
innate immune system.  An evolving hypothesis in this relatively new area of research is 
that in addition to maintaining normal host function, the molecular machinery responsible 
for pathogen recognition and activation of the innate immune response, may also 
contribute to chronic inflammatory diseases if a break down in normal function occurs 
[9].   
 
This thesis focuses on the investigation of NOD-like receptor proteins (NLRs) which are 
involved in intracellular pathogen recognition and activation of the innate immune 
response.  Recent work by others has identified that NOD1 and NOD2, of the NLR 
family, are critical components in intestinal inflammatory diseases [1].  An association 
between NOD1 and NOD2 with autoimmune diseases of the lung, primarily asthma and 
sarcoidosis respectively, has also been described [3,11].   The main goal of this thesis is 
to investigate the intracellular NLRs present in lung epithelium and their role in directing 
innate immune activation.  The specific hypothesis is that NOD1 and NOD2 activate the 
innate protein complex called the “signalosome” leading to NF-κB activation in human 
lung epithelia.   
 
Data presented show that NOD1 and NOD2 along with RIP2, a key signaling protein of 
the NLR pathway, are constitutively present and associate in the lung epithelia.  Upon 
recognition of the PAMP, iE-DAP, NOD1 facilitates physical recruitment of RIP2 
activating the “signalosome”.  Furthermore exposure to the NOD1 specific agonist, iE-
DAP, but not NOD2 specific agonist, MDP, result in increased release of Interleukin 6 
and Interleukin 8 mediated through the activation of the transcription factor NF-κB.  
These findings provide a framework to explain the recognition of gram negative bacterial 
invasion by lung epithelium and provide a valid model for future studies that will 
investigate the proximal entry of PAMPs into the lung epithelium thereby activating the  
“signalosome” upon NOD recognition and signal transduction.   
 
In conclusion our findings indicate that, NOD1 activates the “signalosome” machinery 
resulting in activation of the NF-κB pathway thereby inducing proinflammatory cytokine 
and chemokine release.   This highlights the importance of NOD1 function in bacterial 
clearance and epithelial homeostasis, as well as, a potential for aberrant immune 
responses potentiated by dysregualtion in lung pathogenesis and inflammatory diseases.   
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Introduction 
 
All organisms must protect themselves from attack by foreign invaders.  The vast 
biodiversity among microorganisms requires that the host immune system can function 
effectively in terms of detection and elimination.  Therefore it is no surprise that multiple 
mechanisms of defense have evolved in humans.  The interaction and cooperation, of 
such a network, provides for an accurate and precise defense system; precise by 
distinguishing self from non-self and accurate by eliminating foreign invaders and not 
host tissue.    
 
 
Pulmonary Host Defense 
 
The lumen of the lung is kept sterile by a system of very effective defenses that protect 
the interior of the body.  The first consists of physical and chemical barriers that prevent 
the entrance of infectious agents into tissues of the lung.  The second line of defense 
consists of cellular and chemical defenses that exist to remove and destroy infectious 
agents that have gained entrance to these tissues [10].  These pulmonary defense 
mechanisms are therefore essential in recognizing and removing pathogens, while 
maintaining barrier function and tissue homeostasis in the lung microenvironment.     
 
 
Innate Immune Defense in the Lung 
 
When microorganisms breech the anatomical barrier, additional defense is required. First, 
the system must have the ability to recognize common pathogenic structures that 
distinguish it as foreign[10].  Indeed, the innate immune defense system consists of germ-
line encoded receptors and effecter molecules that recognize highly conserved pathogen 
motifs [11].  These pathogen recognition receptors (PRRs) “sense” the presence of 
invading microbes and recruit effecter molecules that in turn initiate the host defense 
response thereby protecting and ultimately maintaining normal tissue function [9]. A well 
recognized effector cell in this process is the macrophage that upon recognition engulfs 
and digests pathogens thereby effectively killing it.  
 
The Lung Epithelium 
 
The epithelium of the human airway is responsible for forming a barrier that divides the 
airway from the interstitial space [12].  It is a diverse population of ciliated cell types that 
form tight junctions and secrete mucosa and antimicrobial peptides. The mucociliary 
clearance system removes infectious agents from the airway of the lung by propelling 
mucus containing pathogenic particles up the airway were it is eliminated [8].   Also 
present in the mucosal layer are the antimicrobial peptides lysozymes, cathelicidin, and 
beta defensins that inhibit and kill microorganisms [6, 8].  Upon bacterial invasion these 
enzymes liberate bacterial motifs that play a crucial roll in innate sensory recognition and 
immune activation in the lung [9, 11].   Impairment of these functions results in longer 
residence time leading to pathogen colonization, propagation and infection.  The dynamic 
interplay between barrier defense and innate defense is central to lung epithelial function 
and host homeostasis.    
 
Introduction 
 
Molecular Aspects of NOD-mediated Immune Activation 
  
Pathogen-associated molecular patterns (PAMPs) are components of microorganisms that 
are recognized by specific receptors of the innate immune system.  Categorically, three 
pathogen recognition receptor types (PRRs) are known:  extracellular complement, 
transmembrane toll-like receptors (TLRs), and intracellular nucleotide-binding 
oligermerisation domain (NOD) proteins.  We will focus our attention on investigation of 
NOD1 and NOD2 and evaluate their role in pathogen recognition (of PAMPs) in the lung 
epithelium leading to activation of the innate immune system.  PAMP recognition is 
known to occur by NOD proteins via interaction with a luceine rich repeat region (LRR) 
located at their C-terminus.  The amino terminus of NODs harbors a caspase-recruitment 
domain (CARD) that promotes protein interaction with caspase-1 or Receptor Interacting 
Protein 2 (RIP2) [5,9].  RIP2 is a serine-threonine kinase adapter molecule that is 
recruited into the signalosome following PAMP recognition by NODs, leading to NF-κB 
activation and cytokine production [5].   
 
 
Innate Immunity in Health and Disease 
 
Innate immunity is essential for protection of the lung and functions to help maintain 
barrier function and host homeostasis in the lung microenvironment.  However, as shown 
in other disease states, disorders of the innate immune response can lead to disease.  
Immunodeficiency diseases occur when the immune response is less then sufficient 
resulting in life-threatening infection.  Alternatively, autoimmune diseases are the result 
of a hyperactive immune response.   The pathogenesis of such disease is the result of 
dysregulation of the molecular machinery responsible for regulating innate activity.  
 
 
Scope of this Thesis 
 
The general aim of this thesis has been to investigate how the innate immune system 
senses intracellular pathogen invaders and relays that information through an effector 
pathway in the lung epithelia.  In particular, the involvement of intracellular recognition 
of bacterial dipeptides by NOD receptors triggering “signalosome” recruitment and 
subsequent activation of NF-κB –mediated transcription was the subject of our 
investigation.  Based on preliminary studies, our goal became more focused on NOD1.  
    
 
 
 
 
 
   
 
 
 
 
  
 
 
Materials and Methods 
 
  Molecular Biology 
.1  Plasmids 
OD1  
he human full length NOD1 cDNA was a generous gift of the Nunez laboratory.  The 
 Luciferase 
r. Anasuya Sarkar (Wewers laboratory) graciously provided the firefly plasmid.  It was 
 Luciferase 
udarshan Seshadri (Wewers Laboratory) graciously provided the Renilla plasmid.   
.2  Transformation and Propagation of Plasmids 
ote: All plasmids followed the same protocol. 
AX Efficiency® DH5α™ competent cells (Invitrogen) were thawed on wet ice.  100 
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2862 bp cDNA sequence (accession: NM_006092) was inserted into a pcDNA3 vector 
with KpnI and XhoI restriction sites with a CMV promoter region and N-terminal flag 
tag. 
 
-Firefly
 
D
unknown to what construct vector the firefly luciferase was inserted.   
 
- Renilla
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ng of was mixed with 50 µl of competent cells.  Cells were incubated on ice for 30 
minutes followed by a 45 second heat-shock in a 42°C water bath.  Cells were returned to 
ice for 2 minutes upon which 900 µl Super optimal catabolite repression (S.O.C.) 
medium (Invitrogen) was added and then shaken on an orbital shaker at 225 rpm (37°C) 
for 1 hour.  Then on a Luria-Bertani (LB) plus ampicillin agar 100 µl of competent cell 
mixture was spread an incubated at 37°C overnight.    2 ml LB medium and 100 µg/ml 
Ampicillin was inoculated with a single colony and incubated for 6 hours at 37°C with 
vigorous shaking.  Upon which time a 1:500 dilution of starter culture in LB medium was 
incubated overnight at 37°C with vigorous shaking (500 µl : 250 ml) .  2 ml of cultured 
bacteria plus 20% glycerol was stored at -20°C.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
 
1.3  Isolation and Purification of Plasmids 
 
The protocol below is for the Promega Wizard® Plus Midiprep DNA Purification System.  
00 ml of bacterial culture was centrifuged at 6,000g for 15 minutes at 4°C  to pellet the 
.4  Elution and Quantitation of Plasmids 
he midicolumn was placed in a new 1.5 ml tube and 300 µl of (70°C) RNAse/DNAse 
xperiments were performed using sterile technique and a laminar flow hood. Care has 
 
1
cells.  Using 3 ml of Cell Resuspension Solution to suspend the cells an additional 3 ml 
of Cell Lysis Solution was added then added.  Once suspension became clear (no greater 
than 5 minutes) 3 ml of neutralization Solution was added to inhibit further cell lysis.  
Another centrifugation at 14,000g for 15 minutes at 4°C was performed.  Supernatant 
containing DNA was decanted and saved in a 50 ml falcon tube; avoiding white 
precipitant.  10 ml of resin was added to DNA and transferred to Midicolumn.  Vacuum 
was applied; releasing when liquid had passed through the column.  15 ml of wash 
solution containing ethanol was added and vacuum applied once more; again releasing 
vacuum when liquid had passed through the column.  A wash was repeated once more, 
however, this time vacuum was continued for approximately 30 seconds after liquid had 
passed through the column.  The Midicolum was separated from the reservoir and placed 
in a 1.5 ml microcentrifuge tube and centrifuged at 10,000g for 2 minutes.   
 
 
1  
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free water added.  After 1 minute elapsed the tube was centrifuged at 10,000g for 20 
seconds to elute the DNA.  Elute was then centrifuged an additional 5 minutes at 10,000g 
to pellet resin fines.  Supernatant was then transferred to a new centrifuge tube and stored 
at -20°C.  Additionally, a sample 1:49 dilution was performed and using a 
spectrophotometer concentration was determined.   
 
 
2  Cellular Biology 
 
E
been taken to ensure that all solutions were sterilized by autoclaving and/or filtration 
through a 0.22 μm filter unit (Nalgene), and that the DNAs used for tranfection were not 
contaminated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
 
2.1  Biochemicals 
 
All chemicals and reagents used for the studies were of the highest chemical grade and 
rimary human lung upper airway epithelial cells (hUAECs) were isolated by enzymatic 
Culture inserts were washed twice and conditioned in phosphate buffer saline 1X (PBS) 
were available commercially. Ala-γ-D-Glu-Diaminopimelic acid (γ-iE-DAP) and Ala-D-
Glu-DAP (iE-DAP) were purchased from Anaspec (San Jose, CA). N-Acetylmuramyl-L-
alanyl-D-isoglutamine hydrate (MDP) and Glycyl-sarcosine (Gly-Sar) was purchased 
from Sigma (St. Louis, MO).   
 
 
2.2  Primary Cell Culture 
 
P
dissociation of trachea, bronchi, and bronchioles of adult lungs.  Cells were seeded on a 
collagen coated, semi-permeable matrix (0.6 cm2; Millicell-HA, Millipore, Bedford, 
Massachusetts) and grown at an air-liquid interface.  The donor lung was held constant 
for all experiments (TBD 016).  The hUAECs were maintained with a 1:1 mixture of 
Dulbecco's modified Eagle's media andHam's F12 media (DMEM/F12), supplemented 
with 2% Ultroser G (BioSepra; Villeneuve, La Garenne, France) and antibiotics.  24 
hours pre-experiment medium was replaced with DMEM plus 10% fetal bovine serum no 
antibiotics unless otherwise noted.   
 
 
2.2.1  Immune Activation Studies 
for 20 minutes followed by washing with sterile apical transport buffer (AP) (DMEM/F-
12 w/o phenol red, 50:50 mix, pH 6.5).  300 μl of basal transport buffer (BL) (DMEM/F-
12 w/o phenol red, 50:50 mix, pH 7.9; Gibco, Carlsbad, CA) was placed on the 
basolateral side and 100 μl of AP buffer on the apical side.   hLEC’s were treated apically 
with 5 μg/mL of the bacterial dipeptide diaminopimelic acid (γ-ieDAP) or muramyl 
dipeptide (MDP).  For competitive inhibition studies, the apical chamber received a 
10,000-fold excess of GlySar (0.1mM) prior to the bacterial dipeptide challenge.  At the 
end of a 4 hour incubation the hLEC’s were washed three times and placed normal 
culture medium (DMEM plus 10% FBS; Cellgro-Mediatech, Inc.).  The cell supernatants 
from the apical and basolateral chambers was collected and pooled at the end of 24 hours, 
snap frozen, and stored at -80˚C for cytokine analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
 
2.2.2  Cytokine Determination 
 
Measurement of human IL-6 and IL-8 concentrations in cell culture supernatants was 
.2.3  Western Analysis of hUAECs 
ell lysis buffer (Cell Signaling, Beverly, MA) with 1 mM PMSF and 1X Complete 
.2.4  Immunoprecipitation Experiments of hUAECs
Cultured hUAECs were stimulated with 250 units/mL of IFN-γ, or 100 ng/mL of TNF-α.  
performed using the Immulite automated chemiluminometer (Diagnostic Products 
Corporation, Los Angeles, CA) by Dr. Mark Hall.  Manufacturer-supplied standards were 
used for calibration prior to sample analysis.  Samples were measured over a range of 
dilutions to validate accuracy. 
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C
MiniTM protease inhibitor cocktail (Roche) was directly added to the apical surface of the 
transwell chamber after removal of the culture medium from the basolateral chamber. 
Cells were scraped and collected with lysis buffer and then centrifuged at 13,200 rpm for 
10 min at 4°C. Supernatants were quantified by protein assay (Bio-Rad, Hercules, CA) 
and then mixed with Laemmli buffer (Bio-Rad) containing 5% (vol/vol) 2-
mercaptoethanol, boiled for 5 min, separated on 10%  SDS-PAGE gel (Bio-Rad), and 
transferred to a nitrocellulose membrane (Amersham Biosciences, Little Chalfont, UK). 
Membranes were blocked with 5% (wt/vol) nonfat milk in phosphate-buffered saline 
(PBS)-0.1% Tween 20 (PBS/T) for 1 h at room temperature and then incubated with 
primary antibody overnight at 4°C. After washing, the membranes were incubated with 
the secondary antibody for 1 h at room temperature. Signal was detected with an ECL kit 
(Amersham Biosciences) and a Fluor-S Multi-Imager Max/Bio-quantity one (Bio-Rad). 
The following antibodies were used in our experiments: anti-NOD1 (1:1,000; 
IMGENEX, San Diego, CA); anti-NOD1 (1:1,000; Dr. Philpott, Paris, France); anti-RIP2 
(1:1,000; Cell Signaling, Beverly, MA); and goat anti-rabbit IgG-HRP (1:3,000; 
1:10,000; Zymed, San Francisco, CA).  
 
 
2  
After 24 hours cells were recovered and lysed in Cell lysis buffer (Cell Signaling, 
Beverly, MA) with 1 mM PMSF and 1X Complete MiniTM protease inhibitor cocktail 
(Roche).   Lysates were clarified by centrifugation (10 min at 13,200rpm), protein 
quantified (as described above), and aliquoted in 200 μg/200 μL samples.  Samples were 
pre-cleared by incubation of Recombinant Protein G (rProtein G) Agarose (Invitrogen 
Corporation, Carlsbad, California) for 30 minutes with cell lysates.  Immunoprecipitation 
of NOD1 was performed by incubating overnight at 4 °C with commercially available 
anti-NOD1 (2 μL) antibody or pre-immune rabbit serum (2 μL) followed by a 1-hr 
incubation with rProtein G.  Immune complexes were washed extensively with lysis 
buffer, boiled in Laemmli buffer and separated by SDS/PAGE using a 10% gel. Proteins 
were then transferred on to nitrocellulose membranes and detected by immunoblotting 
with the anti-NOD1 antibody from Dr. Philpott. 
 
 
 
 
Materials and Methods 
 
  HEK 293 Cell Line Culture 
EK-293T cells (Human embryonic kidney) were used for some in vitro experiments; as 
.1 NOD1 Expression 
.1.1 Cell Transfection 
ells were plated on a six well plate a day before transfection using DMEM plus 10% 
ote: The amounts of DNA and Lipofectamine are based on the chart below: 
3
 
H
they do not constitutivley express NOD1. They were maintained in Dulbecco's modified 
Eagle medium low glucose 1X (Gibco) supplemented with 10% FBS. Cells were grown 
in an incubator at 37°C in presence of 5 % of CO2. 
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FBS and no antibiotics.  On the day of transfection one sterile 1.5 ml centrifuge tube was 
designated Tube 1 and DMEM medium and DNA was added.  Another was designated 
Tube 2 and DMEM medium and Lipfectamine 2000 (Invitrogen) was added; let this sit 
for 5 minutes. The tubes were then combined into one tube and sat for 30 minutes at 
room temperature.  This allows for the DNA/Lipo to complex.  While waiting for 
complexes to form, cell medium was removed and washed once with DMEM (No FBS).  
After the 30 minutes transpired the DNA/Lipo complexes were gently added to the cells. 
Once added the plate was gently rocked back and forth.  Then additional DMEM was 
added to bring the final transfection volume up to the desired volume.  The tranfections 
were placed inside the 37°C incubator for 2 hours.  After 2 hours the transfection medium 
was washed replaced with DMEM plus 10% FBS and stored overnight in a 37°C  
incubator. 
 
N
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Materials and Methods 
 
3.1.2 Western Analysis 
ing, Beverly, MA) with 1 mM PMSF and 1X Complete 
TM   
 BEAS-2B Cell Line Culture 
e y transforming human bronchial cells with an 
.1 Co-Immunoprecipitation of RIP2 
g  flag tagged NOD1.  24 hours post cells 
 
Cell lysis buffer (Cell Signal
Mini  protease inhibitor cocktail (Roche) was directly added to the surface of the cells.
Cells were scraped and collected with lysis buffer and then centrifuged at 13,200 rpm for 
10 min at 4°C. Supernatants were quantified by protein assay (Bio-Rad, Hercules, CA) 
and then mixed with Laemmli buffer (Bio-Rad) containing 5% (vol/vol) 2-
mercaptoethanol, boiled for 5 min, separated on 10%  SDS-PAGE gel (Bio-Rad), and 
transferred to a nitrocellulose membrane (Amersham Biosciences, Little Chalfont, UK). 
Membranes were blocked with 5% (wt/vol) nonfat milk in phosphate-buffered saline 
(PBS)-0.1% Tween 20 (PBS/T) for 1 h at room temperature and then incubated with 
primary antibody overnight at 4°C. After washing, the membranes were incubated with 
the secondary antibody for 1 h at room temperature. Signal was detected with an ECL kit 
(Amersham Biosciences) and a Fluor-S Multi-Imager Max/Bio-quantity one (Bio-Rad). 
The following antibodies were used in our experiments: anti-NOD1 (1:1,000; 
IMGENEX, San Diego, CA); anti-NOD1 (1:1,000; Dr. Philpott, Paris, France); anti-flag  
(1:1,000; Sigma-Aldrich, St. Louis, MI ); and goat anti-rabbit IgG-HRP (1:3,000; 
1:10,000; Zymed, San Francisco, CA).  
 
 
4
 
h BEAS-2B cell line was derived bT
adenovirus 12-simian virus 40 construct. They were maintained in DMEM supplemented 
with 10% FBS.  BEAS-2B cells were used because of the difficulty in the transfection of 
primary cells and are a good model cell.   
 
 
4
 
he BEAS-2B cell line was transfected with 1 μT
were stimulated with 5 μg/ml iE-DAP for 0, 5, 15, and 30 minutes.  Cells were recovered 
and lysed in Cell lysis buffer (Cell Signaling, Beverly, MA) with 1 mM PMSF and 1X 
Complete MiniTM protease inhibitor cocktail (Roche).   Lysates were clarified by 
centrifugation (10 min at 13,200rpm), protein quantified (as described above), and 
aliquoted in 200 μg/1000 μL samples.  Immunoprecipitation of flag tagged NOD1 was 
performed by incubating overnight at 4 °C with commercially available monoclonal anti-
flag (1 μL) (Sigma) antibody or mouse IgG (1 μL) followed by a 1-hr incubation with 
anti-flag M2 beads (Sigma).  Immune complexes were washed extensively with lysis 
buffer, boiled in Laemmli buffer and separated by SDS/PAGE using a 10% gel. Proteins 
were then transferred on to nitrocellulose membranes and detected by immunoblotting 
with the anti-RIP2 antibody from Dr. Wewers lab. 
 
 
 
 
 
 
 
 
 
Materials and Methods 
 
4.2  NF-κB Activation Study 
he protocol is for the Promega® Luciferase Assay System.  It is important to remember 
ells were transfected, as previously mentioned with HEK 293 cells, this time with 
.2 Small Interfering RNA (siRNA) Assay 
was purchased from Dharmacon 
 
.3 Real-Time PCR 
RIzol reagent followed by reverse transcrition of 2 μg of total 
–
 
 
T
that all reagents and samples equilibrate to room temperature prior to performing an 
assay. 
 
 
C
firefly luciferase.  However, after the two hours of transfection cells were washed once 
and then submersed in 1 ml of AP buffer (pH= 6.5).  A dose of 5 μg/ml of iE-DAP was 
then administered.  The plate was then placed in a 37°C incubator for 0, 2, 6, 12, and 24 
hours.  1X PBS was used to wash the cells and then 100 μl of Passive Lysis Buffer 
(Promega) was added to the surface of the cells.  Cells were scrapped on ice, collected, 
vortexed for 15 seconds, and then centrifuged at 13,200 rpm for 10 minutes at 4°C.   100 
μl of Luciferase Assay Reagent was dispensed into each luminometer tube (two tubes per 
sample).  20 μl of cell lysate was added to a luminometer tube and mixed by pipetting 3 
times.  Then the tube was placed in the luminometer and read.  Luciferase values were 
normalized for transfection efficiency by protein concentration.  NK-κB assays were 
performed once in triplicate. 
 
 
4
 
The following NOD1 siRNA used in this study 
(Lafayette, CO).  BEAS-2B cells were transfected with 5-nM ON-TARGETplus™ 
SMARTpool® siRNA by using HiPerfect transfection reagent (Qiagen, Valencia, CA) 
according to the manufacturer's protocol.  48 hours after transfection, cells were subjected 
to western analysis. 
 
 
4
 
RNA was isolated with T
RNA with ThermoScript RNase H  reverse transcriptase (Invitrogen Corporation, 
Carlsbad, California) then diluted to 100 μl. Between 20 to 60 ng of cDNA was used for 
quantitative PCR with SYBR green I PCR master mixture and the PRISM 7700 apparatus 
(Applied Biosystems). The total volume of the PCR reaction was set at 20 μl and 
included 2 μl of cDNA template and 0.25 μM of each primer.  The NOD1/CARD4 
primer was designed with the following criteria: to give an 80- to 200-nt amplicon, GC 
range of 30–70%, melting temperature of 59–60°C, free of secondary structure, and a 
free-energy change (ΔG) of less than or equal to –7 kcal/mol. Primer pairs intentionally 
spanned introns to avoid false negatives by amplification of genomic DNA. Relative 
copy numbers (RCN) and expression ratios of NOD1 was normalized to two 
housekeeping genes [GAPDH and CAP-1 (cAMP-accessory protein)] and calculated with 
the following equation: RCN = E– Ct × 100 (refer to Gavrilin et al). 
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Results 
titutive Presence of NLRs in Lung Epithelium 
1  RT-PCR  Analysis 
Cs and BEAS-2B cells in fact had the ability to express 
igue 1.1:  Quantitative characterization of transcriptional message expression of 
 
 
  Cons1
 
. 
1.
 
To determine whether hUAE
NOD protein, we examined steady state message RNA levels under baseline and cytokine 
challenged conditions.  RT-PCR analysis was used to quantify NOD expression.  Our 
results show that both hUAECs and BEAS-2B cells express endogenous levels of 
messenger RNA for NOD1 (Fig 1.1 A,B) and NOD2 (Fig 1.1 C,D).  The data also reveals 
NOD1 inducibility by IFN-γ (Fig 1.1 A,B) and NOD2 inducibility by TNF-α  (Fig 1.1 
C,D) and was anticipated based upon the previously published work of others (Ref).  This 
was observed in a parallel fashion across epithelial cultures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F
CARD4/NOD1 in hUAECs.  (A) IFN-γ induces NOD1 mRNA in primary lung 
epithelial cells.  (B) TNF-α induces NOD2 mRNA in primary lung epithelial cells.  RT-
PCR analysis for NOD mRNA following the addition of 250 units/mL IFN-γ, and 100 
ng/mL TNF-α  stimulation for 24hrs.  GAPDH and CAP were used as the internal control 
to standardized and quantify mRNA expression. 
 
 
Results 
 
1.2 Immunoprecipitation (IP) Assay 
NOD1 by Western analysis.  In order to 
IP was performed on both hUAECs and 
EAS-2B cells.  From this we were able to effectively probe NOD1 at 107 Kd under 
 
To confirm protein expression we examined 
concentrate NOD protein in our samples an 
B
baseline, IFN-γ and TNF-α conditions.  Consistent with RT-PCR data, our results show 
both a constitutive and inducible expression of NOD1 protein (Fig 1.2).   
 
 
1.3  Western Analysis 
 
 key molecules involved in the NLR-mediated signalosome
m, cells were analyzed under baseline conditions. Standard 
estern analysis was performed on different cell types and immuno-blotted for RIP2 and 
To determine the presence of
response in the lung epitheliu
 
W
NOD1, both involved in innate immune activation.  Our results catalog the presence of 
RIP2, ASC, ICE, and other essential players in the NLR pathway in the lung epithelium 
(Fig 1.3).   
 
 
 
 
 
 
 
 
 
Results 
 
 
 
 
 Figure 1.3:  Western analysis was performed 
on different cell types that ithelial cell lines A549 and 
EAS2B as well as primary human upper airway epithelia. 
onist 
2 
r resence of NOD1, NOD2 and RIP2 we set out to determine if 
ensitive to NOD specific agonists.  To measure this we ran a 
ytokine profile for Interleukin-6 and Interleukin-8 release in the supernatant of hUAECs 
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2 Immune Activation Upon NOD1 Specific Ag
 
2. Cytokine Assay 
 
Afte  characterizing the p
the lung epithelium was s
c
and BEAS-2B cells following exposure to NOD specific agonists.  Our results show 
increased secretion of IL-6 and IL-8 in primary ( Figure 2.3) and BEAS-2B cells (Figure 
2.2) upon iE-DAP, but not MDP treatment. Based on these findings and knowing that iE-
DAP is specific for NOD1, we turned our attention to NOD1 in subsequent studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
 
 
 
Immune activation upon NOD1 specific agonist, but not NOD2 specific 
hUAECs were treated apically with 5 μg/mL of the bacterial dipeptide
Figure 2.3: 
agonist.   
diaminop γ-ieDAP) or muramyl dipeptide (MDP). The cell supernatants from imelic acid (
the apical and basolateral chambers was collected and pooled at the end of 24 hours for 
cytokine analysis. 
 
 
 
 
Figure 2.2:  Immune activation upon NOD1 specific agonist, but not NOD2 specific 
agonist. BEAS-2B cells were treated apically with 5 μg/mL of the bacterial dipeptide 
iaminopimelic acid (γ-ieDAP) or muramyl dipeptide (MDP). The cell supernatants were 
collected at the end of 24 hours for cytokine analysis.   
d
Results 
 
3 Nuclear factor-kappa B  (NF-κB) Activation 
 
3.1  NF-κB Luciferase Assay 
ng the effects of iE-DAP, 
ownstream activation of the transcription factor NF-κB was measured to elucidate 
 firefly luciferase reporter was overexpressed in the 
EAS-2B cell line.  Cells were treated with iE-DAP following transfection of the 
 
To further confirm the role of NOD1 protein in mediati
d
transactivation of IL-6 and IL-8.  A
B
luciferase plasmid.  Results demonstrate a peak in NF-κB activity as early as 2 hours that 
persisted  out to 24 hours (Fig 3.1).    
 
 
 
 
 
 
 
igure 3.1: Activation of the transcription factor NF-κB upon NOD1 specific agonist 
hallenge.  BEAS-2B cells were transfected with 1 µg of the firefly reporter. Two hours 
ost transfection cells were administered 5 µg/ml iE-DAP for 0, 2, 6, 12, and 24 hours. 
F-κB-mediated luciferase was expressed as early as 2 hours post treatment. Luciferase 
F
c
p
N
units were normalized to total protein concentrations 
 
 
 
 
 
 
 
 
 
Results 
 
3.2  Dual NF-κB Luciferase Assay 
n order to validate specificity of the firefly reporter assay an internal contr
corporated to normalize the relative luciferase units measured upon iE-DAP treatment.  
 a dual luciferase assay was performed.  Our 
y increases with a decrease in renilla reporter 
 
I ol was 
in
A pilot study to optimize the conditions of
esults show that 1) Firefly reporter activitr
concentration (Figure 3.2A) and that renilla reporter shows decreased sensitivity in a dose 
dependent manner (Fig 3.2B).  Thus, a 1:10,000 fold dilution of renilla plasmid will be 
used in future studies involving the activation of the transcriptional factor NF-κB. 
 
NF-κB Luc 
A 
B 
 
 
 
Figure 3.2: Optimization parameters of the dual luciferase assay.  (A) Firefly reporter 
activity increases with a decrease in renilla reporter concentration.  (B)  renilla reporter 
in a dose dependent manner shows decreased sensitivity 
 
 
 
 
 
 
 
 
 
 
Results 
 
4  NOD1 Activates the Signalosome  
.1  Transfection of Flag Tagged NOD1  
rally express NOD1, was transfected with 
ruct.  Western analysis was performed to 
 confirms successful transfection and 
ansfection efficiencies over 70% are 
of  iE-DAP followed by IP 
tibodies and the indicated time points.  
nti-human-RPI2 antibody. The results show 
 
Figure 4.1: Transfection studies using NOD1-flag  (A) Expression of NOD1-
protein after transfection into HEK-293 cells. Western analysis was performed on HEK-
293 cells by loading 40 µg whole cell lysate on a 10% gel and immuno-blotted with 
monoclonal anti-flag antibody (Sigma). (B) Interaction between NOD1 and RIP2 upon 
 
4
 
HEK-293 cells, a cell line that does not natu
μg of a Flag-tagged NOD1 plasmid const1
evaluate NOD1 protein expression.  Figure 4.1A
overexpression of NOD1 in HEK-293 cells.  Tr
routinely achievable (data not shown). 
 
4.2  Co-Immunoprecipitation Study 
 
Transfection of Flag-tagged NOD1 was performed in BEAS-2B cells.  At 24 hours post-
ansfection, cells were exposed to increasing concentrations tr
pull-down of cell lysates with Flag an
mmunoblots were then conducted with an aI
physical recruitment of RIP2 (to NOD1) at 15 and 30 minutes (Fig 4.1B).  From this we
conclude that NOD1 and RIP2 interaction, a key step in initiating formation of the  
signalosome, occurs following recognition of the gram-negative bacterial dipeptide iE-
DAP.  
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flag 
NOD1 agonist in BEAS-2B cells. Co-Immunoprecipitation of RIP2 was performe
BEAS-2B whole cell extracts following treatment with 5μg/mL iE-DAP in a time 
dependent manner. Mouse IgG was used as a negative isotype control. Lysates were 
immunoprecipitated with monoclonal anti-Flag antibody (Sigma) and then immuno-
blotted with anti-RIP2 antibody (rabbit).  
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Results 
 
5  NOD1 Silencing  
5.1  siNOD1 Experiment 
med using four small interfering RNA’s that are complimentary 
 with siNOD1 and then treated with IFN-γ 
metry was used to quantify protein expression.   Results 
rotein expression in the BEAS-2B cell (Figure 5.1).  This 
 
 
A pilot study was perfor
 NOD1 mRNA.  BEAS-2B cells were treatedto
and blotted for NOD1.  Densito
how 98% inhibition of NOD1 ps
will allow us to further address the essential requirement and specificity of NOD1 in 
future studies. 
 
 
Nod1
B-Actin  
 
 
Figure 5.1: Suppression of NOD1 protein expression.  BEAS-2B cells were 
transfected with siNOD1.  24 hours later cells were stimulated with 250 U/ml IFN-γ for 
med on whole cell lysates with 80 g of total 
rotein loaded on a 10% gel and immuno-bloted with anti-NOD1/Card4 antibody 
24 hours. Western analysis was perfor
p
μ
(IMGENEX) 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
Discussion 
To date, studies involving NOD-mediated immune activation has largely focus
hagocytes and gut epithelium.  Based on literature review, there are no studies involving 
 Our first experiments set out to characterize the presence of NOD1 and 
OD2 and at the same time, catalog the presence of other NLR-related effector 
g in signal 
ansduction and immune activation. Our results demonstrate that iE-DAP specifically 
y result 
llowing NF-κB activation thereby resulting in cytokine and chemokine production and 
 with NOD1 through a homophilic -CARDCARD interaction. Our preliminary 
sults show supportive evidence that physical recruitment of RIP2 to NOD1 occur upon 
 
 
ed on the 
p
lung epithelia.
N
molecules.  Our results demonstrate the endogenous expression of NOD1 and NOD2  
mRNA and NOD1, RIP2, ICE, and ASC protein in the lung epithelium.  Work by others 
had previously reported that the pro-inflammatory cytokines IFN-γ and TNF-α induce 
NOD1 and NOD2 expression, respectively, in gut epithlia (1).  Our data shows an 
identical response in the lung epithelium proving that NOD protein exists constitutively 
and can also be induced following cytokine exposure (acute inflammation).    
 
The next phase of investigation was to determine NOD-mediated immune activation by 
NOD specific agonists.  It has been reported that iE-DAP and MDP are the minimal di-
peptides required for NOD1 and NOD2 recognition, respectively, resultin
tr
induces IL-6 and IL-8; key markers of the innate immune response.  Alternatively, MDP 
did not lead to immune activation as measured by IL-6 and IL-8 release, suggesting that 
NOD1, but not NOD2, plays a critical role in NLR signaling and activation of the innate 
immune response.  Since both NOD proteins are present in the lung epithelium it may be 
that proximal events determine NOD recognition although this remains to be studied.  
The mechanism by which these di-peptides gain entrance into the cell has also not been 
elucidated.  This is an important question that will be addressed in future studies. 
 
The promotor regions of both IL-6 and IL-8 become activated by the transcription factor 
NF-κB.  Results from the firefly luciferase assay demonstrate that iE-DAP induces 
activation of the NF- κB pathway.  This suggests that NOD1-mediated events ma
fo
release.  NOD1-mediated participation of NF-κB-mediated expression of other innate 
immune effector molecules is an important question to be addressed in future studies.  
Our results, however, do not rule out the possibility that iE-DAP may be activating 
additional signaling pathways.  In future studies we will utilize the NF-κB-mediated 
promotor dual luciferase assay and NOD1-specific small interfering RNA knockdown to 
determine if NOD1 is an essential requirement for the lung epithelial response to iE-
DAP.   
 
How NODs mediate the activation of the NF-κB pathway is still poorly understood.  
RIP2 an adaptor protein with a serine threonine kinase and a caspase recruitment domain 
interacts
re
iE-DAP exposure. This supports the concept that binding of NOD1 and RIP2 activates a 
multimeric protein complex of other signal-transducing molecules coined the  
“signalosome” thereby activating the transcription factor NF-κB.   These intermediary 
signaling molecules leading to NF-κB activation by NOD1 will be also be evaluated in 
future studies.   
 
 
 
Discussion 
 
In summary, our results demonstrate that the innate immune recognition of bacteria 
volves the lung epithelium, in addition to other immune type cells.  Mounting evidence 
suggests a vital role for NOD1 in bacterial recognition and activation of the signalosome 
complex thereby activating transcription factor NF-κB releasing IL-6 and IL-8.  Thus, 
ng epithelial cells which largely constitute the physical front line defense against 
in
lu
microbes, also play an important role through sensory perception and the expression of 
proinflammatory cytokines and chemokines that can recruite additional inflammatory 
cells into the lung microenvironment to enhance host defense.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
References 
 
References 
[1]  Barnich, N., Aguirre, J.E., Reinecher, H.C., Xavier R., Podolsky, D.K. (2005). 
Membrane Recruitment of NOD2 in Intestinal Epithelial Cells is Essential for 
Factor-κB Activation in Muramyl Dipeptide Recognition. Journal of Cell 
 
Nuclear 
Biology 130(1)., 21-26.  
 
[2]  Girardin, S.E., Hugot, J.P., Sansonetti, P.J. (2003). Lessons from NOD2 Studies: 
Towards a link Between Crohn’s Disease and Bacterial Sensing. Review Trends in 
Immunology 24(12)., 652-658.  
 
[3]  Hysi, P., Kabesch, M., MOffatt., Schedel, M.F., Carr,D., Zhang, Y., Boardman,B., 
Mutius, E.v., Weiland, S.K., Leupold, W., Fritzch, C., Klopp, N., Musck, A.W., 
James, A., Nunex, G., Inohara, N., Cookson, W.O. (2005). NOD1 variation, 
immunoglobulin E and Asthama. Human Molecular Genetics 14(7)., 935-941. 
  
[4]  Takahashi, Y., Isuzugawa, K., Murase, Y., Imai, M., Yamamoto, S., Iizuka, M., 
Akira, S., Bahr, G.M., Momotani, E., Hori, M., Ozaki, H., Imakawa, K. (2006). Up-
Regulation of NOD1 and NOD2 through TLR4 and TNF-α in LPS-treated Murine 
Macrophages. Journal of Veterinary Medical Science 68(5)., 471-478.  
  
[5]  Sarkar, A., Duncan, M., Hart, J., Herlein, E., Guttridege, D.C., Wewers, M.D. 
(2006). ASC Directs NF-κB Activation by Regulating Receptor Interacting Protein-
2 (RIP2) Caspase-1 Interactions. Journal of Immunology 176, 4979-4986. 
 
[6]  Pizzichini, E., Pizzichin M.M., Efthimiadis, A., Doovich, J., Hargreave, F.E. 
(1997). Measuring Airway Inflammation in Asthma: Eosinophils and Eosinophilic 
Cationic Protein in Induced Sputum Compared with Peripheral Blood. Journal of 
Allergy and Clinical Immunology 99(4)., 539-544. 
  
[7]  Finkelstein, R., Fraser, R.S., Ghezzo, H., Cosio, M.G. (1995). Alveolar 
Inflammation and its Relation to Emphysema in Smokers. American Journal of 
Respiratory and Critical Care Medicine 152 (5)., 1666-1672. 
  
[8]  Munger, J.S., Huang, X., Kawakatsu, H. Griffiths, M.J., Dalton, S.L., Wu, J., Pittet, 
J.F., Kaminski, N., Garat, C., Matthay, M.A., Rifkin, D.B., Sheppard, D. (1999). 
The Integrin α v. β 6 Binds and Activates Latent TGF-β1: A Mechanism for 
Regulating Pulmonary Inflammation and Fibrosis. Cell 96(3)., 319-328.   
  
[9]  Inohara, N., Chamaillard, M., McDonald, C., Nunez, G. (2005). NOD-LRR 
Proteins: Role in Host-Microbial Interactions and Inflammatory Disease. Annual 
Review of Biochemistry 74., 355-383.  
  
[10] Nester, E., Anderson, D., Roberts, C., Pearsall, N., Nester, M. (2004). Microbiology: 
A Human Perspective. (4th Ed). Mc-Graw-Hill.  New York, NY. Chapter 15.   
 
 
 
 
 References 
 
[11]  Strober, W., Murray, P., Kitani, A., Watanabe, T. (2006). Signalling path
molecular interactions of NOD1 and NOD2. Nature Reviews Immunology
ways and 
 6, 9-20.   
[12]  Karp PH, Moninger TO, Weber SP, Nesselhauf TS, Launspach JL, Zabner J, 
 
Welsh MJ. (2002). An in vitro model of differentiated human airway epithelia.  
Methods for establishing primary cultures.  Methods Mol Bio 188, 115-137. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
